←
Loading live data…
PRICE
Loading…
REVENUE MIX
Total Revenue100%
COST
COGS38%
R&D + SG&A42%
Op Margin20%
FINANCIAL HEALTH
REVENUE
$70.9B
Growth
13%
Gross M.
62%
P/E
20.5
EV/EBITDA
0
Net M.
16%
FCF M.
0%
D/E
6.28
Op M.
20%
PLUG INTO YOUR DCF
Historical growth
16%
Analyst 5y growth
—
Forward P/E
16.9
PEG ratio
1.60
Trailing EPS
$16.60
Forward EPS
$20.10
🚩 RED FLAG SCANNER — 10-K RISK FACTORS, YEAR OVER YEAR
TAM
SIZE
—
CAGR
—
Market-size estimates aren't available for this stock right now — see Financial Health and Risk Assessment below for a fundamentals-based read instead.
RISK ASSESSMENT
LOWA mechanical base-case DCF (default assumptions) implies 37% upside to $466.24 — take this as a rough, unverified estimate, not a target.
HIGDebt/equity of 6.28 — elevated leverage, sensitive to rate/refinancing risk.
LOWRevenue growing 13% YoY — steady, unspectacular growth.
🐂 BULL
AXP shows revenue grew +12.8% YoY, 20% operating margin, 34% ROE — a business converting growth into real profit.
🐻 BEAR
At a P/E of 20.5, the stock is priced for continued execution — any deceleration in growth or margin compression would likely pressure the multiple.
AI-powered data, computed by TreasureX · May contain inaccuracies
⚠️
All values, scores, and figures here are computed from your own assumptions and public data, for educational purposes only. This is not investment advice — TreasureX does not recommend buying or selling any security. Results change with your inputs. Please do your own research and use your own judgement before making any investment decision.